cidofovir anhydrous has been researched along with Herpes Genitalis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Moty, SG; Andrei, G; Hayallah, AM; Mohammed, AF; Simons, C; Snoeck, R | 1 |
| Bertin, C; Blaizot, R; Couppié, P; Jumpertz, M | 1 |
| Gormley, RH; Kovarik, CL; Rosenbach, M; Wanat, KA | 1 |
| Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M | 1 |
| Alessi, E; Cusini, M; Ghislanzoni, M; Zerboni, R | 1 |
| Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Elia, G; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M; Thiry, E; Thiry, J | 1 |
| Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G | 1 |
| Bravo, FJ; Kern, ER; Kier, AB; Stanberry, LR; Vogt, PE | 1 |
| Diaz-Mitoma, F; Hughes, A; Jaffe, HS; McGuire, B; Rudy, J; Sacks, SL; Safrin, S; Shafran, SD; Sibbald, RG; Trottier, S | 1 |
| Norwood, CW; Oster, CN; Sparling, JD; Turiansky, GW | 1 |
| Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B | 1 |
1 trial(s) available for cidofovir anhydrous and Herpes Genitalis
| Article | Year |
|---|---|
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.
Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gels; Herpes Genitalis; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence | 1998 |
10 other study(ies) available for cidofovir anhydrous and Herpes Genitalis
| Article | Year |
|---|---|
Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives.
Topics: Acyclovir; Antiviral Agents; Guanine; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Models, Molecular | 2019 |
Intravenous cidofovir for pseudotumoral genital herpes simplex virus infection in two persons living with human immunodeficiency virus (HIV).
Topics: Cidofovir; Genitalia; Herpes Genitalis; Herpes Simplex; Herpesvirus 2, Human; HIV; HIV Infections; Humans | 2023 |
Intralesional cidofovir for treating extensive genital verrucous herpes simplex virus infection.
Topics: Antiviral Agents; Cidofovir; Coinfection; Cytosine; Hepatitis C; Herpes Genitalis; HIV Infections; Humans; Injections, Intralesional; Male; Middle Aged; Organophosphonates | 2013 |
Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens.
Topics: Animals; Antiviral Agents; Base Sequence; Cidofovir; Cytosine; Disease Models, Animal; DNA Primers; DNA, Viral; Female; Genital Diseases, Female; Goat Diseases; Goats; Herpes Genitalis; Herpesviridae Infections; Humans; Organophosphonates; Species Specificity; Vaginal Creams, Foams, and Jellies; Varicellovirus | 2008 |
Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
Topics: Acyclovir; Administration, Topical; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Organophosphonates | 2006 |
Potent inhibition of genital herpesvirus infection in goats by cidofovir.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Goats; Herpes Genitalis; Herpesviridae Infections; Organophosphonates; Varicellovirus | 2007 |
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; DNA Restriction Enzymes; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral; Thymidine Kinase | 1994 |
Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
Topics: Acyclovir; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Herpes Genitalis; Mice; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Ultraviolet Rays; Vagina; Vaginal Diseases; Virus Replication | 1993 |
Diagnostic and therapeutic dilemmas of a large scrotal lesion in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Diagnosis, Differential; Fluorescent Antibody Technique, Direct; Herpes Genitalis; Herpesvirus 2, Human; Humans; Hyperplasia; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Scrotum; Skin; Skin Ulcer | 2001 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation | 2001 |